ArticleJAMA network open2026
Health Care-Associated Infections Among Neonates During the COVID-19 Pandemic.
Article in JAMA network open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
22 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Importance: Neonatal intensive care units (NICUs) implemented enhanced infection prevention measures during the COVID-19 pandemic to interrupt viral transmission. It was hypothesized that these measures would also reduce nonviral health care-associated infections (HAIs). Objective: To compare rates of viral and bacterial or fungal HAIs in infants admitted to the NICU before and during the pandemic. Design, Setting, and Participants: This cohort study was conducted at 12 level 3 or level 4 NICUs in the US and Canada. Participants were inborn and outborn infants admitted from March 1, 2018, to July 31, 2022, for at least 1 overnight stay at participating NICUs. Data analyses were performed from September 1, 2023, to July 28, 2025. Exposure: The viral and bacterial or fungal HAI rates during the pandemic (April 1, 2020, to July 31, 2022) were compared with those before the pandemic (March 1, 2018, to March 31, 2020). Main Outcomes and Measures: HAI incidence before and during the pandemic was expressed as episodes per 1000 patient-days and compared using pre-post and time series analysis with Poisson regression. HAI was defined as an infection diagnosed 3 or more days after admission and was confirmed using molecular diagnostics for viruses and culture of blood, cerebrospinal fluid, or urine for bacteria or fungal pathogens. Results: The full cohort comprised 48 475 infants, grouped into the viral HAI or bacterial or fungal HAI subpopulations. Among 41 889 infants with 966 025 patient-days admitted at 11 NICUs, 231 (mean [SD] gestational age, 30.5 [5.3] weeks; 147 males [63.6%]) had 241 episodes of viral HAI. Viral HAI rates decreased from 0.35 to 0.16 per 1000 patient-days with an adjusted rate ratio (aRR) of 0.45 (95% CI, 0.34-0.59). Reduced rates persisted during the later pandemic period (April 1, 2021, to July 31, 2022) compared with the corresponding period before the pandemic (aRR, 0.58; 95% CI, 0.42-0.80), even as viral infections in the community increased. Among 48 475 infants with 1 130 038 patient-days at 12 study NICUs, 1537 (mean [SD] gestational age, 29.4 [5.2] weeks; 930 males [60.5%]) had 1969 episodes of bacterial or fungal HAI. Bacterial or fungal HAI rates did not decrease from before to during the pandemic (1.70 to 1.78 per 1000 patient-days; aRR, 1.04; 95% CI, 0.95-1.14). At the site level, changes in bacterial or fungal HAI rates did not correlate with viral HAI rates. Conclusions and Relevance: This cohort study found that viral HAIs decreased significantly during the pandemic, while bacterial or fungal HAIs did not. These findings suggest that the enhanced infection prevention measures used during the pandemic may be beneficial during periods of high viral activity but offer limited additional benefit for preventing bacterial or fungal HAI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.